Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026

FDA approves 2 implantable heart devices from Biotronik

These devices were built to provide better patient data and improve clinician workflows. They will be on display at Heart Rhythm 2026 in Chicago. 

Clinic selling electrical stimulation pain relief pays $380K to resolve fraud allegations

The U.S. Department of Justice said Wisconsin-based Apple Clinic and its owner Michael Johnson, MD, were using a combination of nerve density testing, vitamin injections and electrical stimulation to alleviate pain, billing Medicare for these medically unnecessary services. 

FDA clears Philips Rembra platform

FDA clears Philips' CT platform that streamlines and coordinates workflows

The product expands the capabilities of computed tomography within both diagnostic and radiation therapy settings, improving coordination between care teams. 

doctor patient elderly check up hospital

Heart failure experts agree: HFmrEF should not be ignored

Data on the treatment and management of HFmrEF are limited, but a new scientific statement from the Heart Failure Society of America highlights how important it is to take this condition seriously.

Surgeons Operating On Patient

When bioprosthetic mitral valves fail: Redo surgery bests transcatheter treatment after 5 years

Short-term outcomes were comparable, but long-term data revealed a significant difference in all-cause mortality.

Nathan McConkey, DO, MPH, an electrophysiologist with Oregon Health & Science University (OHSU), made history when he used the Magic Magnetic Interventional Ablation Catheter.

Cardiologist makes ‘Magic,’ performs first procedure in US with new-look ablation catheter

Users guide the robotically navigated catheter using computer-controlled magnetic fields. It gained FDA approval in January.

cardiologists going through the certification process

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Researchers explored data from more than 8,000 patients treated over a three-year period. 

Nicholas Marston, MD, MPH assistant professor of medicine, and a cardiologist at Brigham and Women's Hospital, presented the late-breaking VESALIUS-CV data on the use of evolocumab for the reduction of major cardiovascular events in patients who do not have significant atherosclerosis. #ACC26

Evolocumab reduces risk of major cardiac events in diabetic patients

Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial. 

Displaying 25 - 32 of 7299
Design by Adaptive Theme